KGK Science Inc.   Report issue

For profit Phase 1 Phase 2
Founded: London CRO United States (1997)

Organization Overview

First Clinical Trial
2008
NCT01873820
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

KGK Science | KGK Science Inc. | KGK Synergize | KGK Synergize Inc. | Marealis AS | Qualified Investigator